Penetration of doripenem in human brain: an observational microdialysis study in patients with acute brain injury

Int J Antimicrob Agents. 2012 Apr;39(4):343-5. doi: 10.1016/j.ijantimicag.2011.11.019. Epub 2012 Feb 9.

Abstract

Concentration-time profiles of unbound doripenem were determined by microdialysis in the cerebral interstitium of five patients with acute brain injury. The ratio of the area under the concentration-time curve in brain to that in plasma (AUC(brain)/AUC(plasma)) was 0.17 in one patient and 0.01 in the remaining four patients. Based on the percentage of the dosing interval during which the doripenem concentration exceeded a certain minimum inhibitory concentration (T>MIC), a value of ≥35% of the dosing interval was reached for pathogens with MICs up to 0.05 mg/L. The present data indicate that breakpoints based on concentrations of doripenem in plasma may overestimate antimicrobial activity in brain parenchyma.

MeSH terms

  • Aged
  • Anti-Bacterial Agents / metabolism
  • Anti-Bacterial Agents / pharmacokinetics
  • Area Under Curve
  • Bacteria / pathogenicity
  • Bacterial Infections / blood
  • Bacterial Infections / drug therapy*
  • Bacterial Infections / microbiology
  • Brain / metabolism*
  • Brain / microbiology
  • Brain Injuries / metabolism*
  • Carbapenems / metabolism
  • Carbapenems / pharmacokinetics*
  • Doripenem
  • Female
  • Humans
  • Male
  • Microbial Sensitivity Tests
  • Microdialysis
  • Middle Aged
  • Plasma / metabolism
  • Time Factors

Substances

  • Anti-Bacterial Agents
  • Carbapenems
  • Doripenem